Parkinsons Disease Related Content
PKG (Personal Kinetigraph): Helping my Parkinson’s Disease patients
Parkinson’s Disease affects all activities of patient daily living but PKG can help.
Amyloid Research Consultants
Amyloid Research Consultants enable research targeting root causes of diseases such as Alzheimer’s, Parkinson’s, and diabetes.
Global Kinetics – Parkinson’s disease management
Global Kinetics aim to improve the lives of those with Parkinson’s disease with advanced medical technologies.
NHS Parkinson’s watch to help manage care at home
A Parkinson's watch is being given to patients with the condition, in an effort to improve NHS remote monitoring.
FDA approves new non-invasive brain surgery for Parkinson’s symptoms
Research shows that a new form of non-invasive brain surgery using a focused form of ultrasound will prove invaluable for with Parkinson’s symptoms.
Death rate from Parkinson’s disease rises in US
The death rate from Parkinson’s disease has risen by 63% in the United States, according to a new study.
JPND: Enabling collaborative research in Alzheimer’s and Parkinson’s diseases
Professor of Neurology Thomas Gasser, JPND’s Scientific Advisory Board Chair and Director of the Department of Neurodegenerative Diseases, shares in an interview JPND’s innovative research and collaboration efforts in the universal race against Alzheimer’s and Parkinson’s diseases.
Chemistry analysis: Microfluidic detection of intracellular nitric oxide levels
Jay Sibbitts, Prof Dr Stefan H. Bossmann and Prof Dr Christopher T. Culbertson, from Kansas State University, Department of Chemistry in the U.S., underline microfluidic detection of intracellular nitric oxide levels.
Early diagnosis of neurodegenerative disorders: Where are we now?
Dr Gerry Morrow shares his thoughts on the current state of play when it comes to the early diagnosis of neurodegenerative disorders, and asks the questions, can we screen, and should we screen?
New research may benefit patients with early stage Parkinson’s disease
A new study published in the Movement Disorders journal, has paved the way for more research into identifying markers of progression for patients in the early stages of Parkinson’s disease
National Institutes of Health scientists adapt new brain disease test for Parkinson’s
National Institutes of Health scientists develop new brain disease test for the early diagnosis of Parkinson’s disease and dementia with Lewy bodies
The group, led by NIH’s National Institute of Allergy and Infectious Diseases (NIAID), tested 60 cerebral spinal fluid samples, including 12 from people with Parkinson’s disease, 17 from...
Table Tennis Scotland batting for dementia
Table Tennis Scotland awarded £45,000 to become dementia friendly
Table Tennis Scotland is receiving £35,000 from the Life Changes Trust and £10,000 from Sportscotland to become dementia friendly.
Table Tennis Scotland successfully ran two pilot projects in Dundee and Haddington for over 50's with dementia and Parkinson's disease.
As a result, they are now...
Positive progress for people with Parkinson’s
The European Parkinson’s Disease Association (EPDA) provide an update about the positive progress being made for people with Parkinson’s
My PD Journey is a multi-stakeholder European coalition led by the European Parkinson’s Disease Association (EPDA) and it is a positive development in terms of the positive progress being made for...
PET imaging of neurodegenerative diseases
Prof. Dr Axel Rominger from the Ludwig-Maximilian-University of Munich on how neurodegenerative diseases can be studied through PET imaging
Treatments and symptoms of Parkinson’s
Prof. David Dexter, deputy director of research at Parkinson’s UK shares his thoughts on the symptoms of Parkinson’s and the chances of finding a cure
What’s new in Parkinson’s rating scales?
Parkinson’s rating scales are a vital assessment tool, but have their limitations. Jennifer Stratten explains how and why the EPDA developed a new one
World Parkinson’s Day: uniting to raise awareness
Today, stakeholders from across the globe will unite to raise awareness of Parkinson’s during a dedicated campaign
The role of physiotherapy for Parkinson’s
Writing on behalf of the Chartered Society of Physiotherapy, Dr. Bhanu Ramaswamy highlights how physiotherapy can help manage the symptoms of Parkinson’s
How the retreat of big pharma leads to lost opportunities for Parkinson’s drug discovery
The changing pharma landscape means opportunities for Parkinson's drug discovery are missed, but Parkinson's UK has a new strategy to redress the balance
This will be the 200th year since James Parkinson wrote his seminal paper on ‘the Shaking Palsy’. Since that time there have been major developments in the...
Time for a change of tack on drug development for neurodegenerative diseases?
UCB's Duncan McHale outlines why reclassification might be a good idea to boost drug development for neurodegenerative diseases like Alzheimer's and Parkinson's
Neurodegenerative diseases are a growing global challenge, as medical advances ensure more individuals live longer. By 2020 there will be more than 40 million people in the world...